Position in VRTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,476,123,103
+$35,973,834 QoQ
Shares Held
2,971,681
-6.5% QoQ
Ownership
1.17%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#19
of 1,705 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORGES BANK holds $7,365,469,141 across 55 Biotechnology names. VRTX ranks #1 (20.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
2,971,681 | $1,476,123,103 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,172,808 | $731,292,700 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,271,813 | $683,883,867 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
8,207,954 | $469,659,127 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,157,479 | $404,052,667 | |
| 6 | INSM |
INSMED Inc
|
3,377,641 | $360,124,083 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,896,536 | $317,606,649 | |
| 8 | RPRX |
Royalty Pharma plc
|
5,336,084 | $299,194,229 |
All Filings in VRTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,476,123,103 | 2,971,681 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $1,440,149,269 | 3,176,613 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $1,593,974,491 | 3,580,356 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,631,007,203 | 3,364,150 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $1,374,948,274 | 3,414,324 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,585,821,412 | 3,409,782 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $1,607,281,189 | 3,429,086 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,445,457,679 | 3,457,950 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $1,237,876,564 | 3,042,288 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $929,824,072 | 2,673,906 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $918,101,870 | 2,608,911 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $796,792,810 | 2,528,939 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $707,950,234 | 2,451,521 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $662,604,182 | 2,288,472 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $627,433,050 | 2,226,598 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $684,980,485 | 2,624,748 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $588,505,820 | 2,679,899 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $458,223,790 | 2,526,180 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $513,638,310 | 2,547,430 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $566,777,962 | 2,637,526 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $654,975,186 | 2,771,326 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $778,876,558 | 2,862,254 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $779,889,654 | 2,686,403 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $603,896,398 | 2,537,913 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||